Across the street from MD Anderson, at Texas Children's Hospital, Fivecoat's then-nearly 1-year-old granddaughter Whitney was ...

LOUISVILLE, Ky. -- More than half of patients with newly diagnosed metastatic kidney cancer responded to a novel drug ...

Seattle-based Fred Hutch Cancer Center named Nicole Fleming, MD, as its inaugural deputy chief medical officer. For the last 13 years, Dr. Fleming worked at The University of Texas MD Anderson Cancer ...

Nektar continues to make progress with rezpegaldesleukin, with results from phase 2 atopic dermatitis study expected in H1'25 ...

In a small subset of those patients, the combination resulted in a strong response with tumor shrinkage and no disease ...

A new drug strategy that regulates the tumor immune microenvironment may transform a tumor that resists immunotherapy into a ...

In April 2009, Heaven & Hell released their sole studio album, The Devil You Know, to widespread acclaim. It should have been ...

A live audio webcast of the presentation can be accessed through the Investors section of the Company’s website at www.mereobiopharma.com/investors. An archived replay of the webcast will be available ...

Swayampakula Ramakanth, an analyst from H.C. Wainwright, maintained the Buy rating on Nanobiotix (0QAV – Research Report). The associated ...

Dr. Aloia joined Ascension three years ago after previously serving as professor of surgical oncology and chief value and quality officer at University of Texas MD Anderson Cancer Center in Houston, ...

Scientists have designed a groundbreaking painkiller that activates solely at chronic pain sites, offering targeted, ...

Q3 2024 revenue was $6.1 million, which comprises $6.6 million in core product and software sales which is offset by $0.5 million because of a write-down of aged receivables tied to discontinued ...